Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS

Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS

US Patent 11446329 · Granted Sep 20, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lyophilized compositions containing umbilical cord lining stem cells conditioned2025
Charged depth filtration of antigen-binding proteins2021
Natural killer cells with enhanced viability, proliferation and cytotoxicity fol2021
Natural killer cells with enhanced viability, proliferation and cytotoxicity fol2021
Natural killer cells and methods for enhancing viability, proliferation and cyto2020
Natural killer cells and methods for enhancing viability, proliferation and cyto2020
Umbilical cord lining stem cells and methods and material for isolating and cult2014
Process and device for facilitating the implantation of biological material2004
Recombinant HIV and modified packaging cells and method for using2000
Recombinant HIV and modified packaging cells and method for treating acquired im1998